Quality Assurance and Monitoring
Quality Assurance and Monitoring ensures strict compliance with regulatory standards and study protocols. We implement audits and risk-based monitoring to maintain data integrity and patient safety. Our processes align with ICH-GCP and global guidelines for consistent quality and performance.
We provide comprehensive Quality Management System (QMS) support to ensure your trial meets ICH-GCP, GLP, and GMP standards. Our goal is to shift from reactive “fixing” to proactive “assurance.”
GxP Auditing: Independent site, vendor, and system audits to identify compliance gaps before regulatory inspections.
CAPA Management: Robust Root Cause Analysis (RCA) and Corrective and Preventive Action (CAPA) planning to mitigate recurring risks.
SOP Development: Crafting high-impact, lean Standard Operating Procedures that balance compliance with operational agility.
Inspection Readiness: Mock FDA/EMA inspections and “War Room” support for real-time regulatory audits.
Our monitoring services prioritize data integrity and patient safety through a Risk-Based Monitoring (RBM) framework. We move beyond traditional 100% Source Data Verification (SDV) to a more intelligent, centralized approach.
Risk-Based Quality Management (RBQM): Implementation of targeted monitoring strategies that focus on Critical to Quality (CtQ) factors.
Centralized Statistical Monitoring: Utilizing advanced analytics to identify site performance outliers, data trends, and potential fraud.
Analytical Laboratory Monitoring: Expert oversight of bioanalytical method validation, sample chain-of-custody, and 21 CFR Part 11 compliant data transfers.
Remote Source Data Review (rSDR): Secure, off-site verification of critical study documents to reduce site burden and operational costs.
